A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis

Trial Profile

A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs AK 001 (Primary)
  • Indications Nasal polyps
  • Focus Therapeutic Use
  • Sponsors Allakos
  • Most Recent Events

    • 03 Aug 2017 This study has been suspended in Netherlands as per European Clinical Trials Database.
    • 31 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
    • 31 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top